Register entry
SUN PHARMACEUTICAL IND LTD, MUMBAI
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 0
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Dapagliflozin | powder | 62756-171BULK INGREDIENT |
Compare
Other companies listing dapagliflozin
- Dr. Reddy's Laboratories Limited15 sites · 683 NDC
- Lupin Limited14 sites · 506 NDC
- Zydus Lifesciences Limited12 sites · 717 NDC
- Biocon Biologics Limited9 sites · 176 NDC
- Granules Pharmaceuticals Inc.8 sites · 302 NDC
- MSN Laboratories Private Limited,8 sites · 275 NDC
- Aurobindo Pharma Limited6 sites · 1,453 NDC
- Sandoz Industrial Products S.A5 sites · 441 NDC
- Honour Lab Limited4 sites · 96 NDC
- HARMAN FINOCHEM LIMITED4 sites · 55 NDC
Enquiry
Common questions
- Is SUN PHARMACEUTICAL IND LTD, MUMBAI FDA approved?
- SUN PHARMACEUTICAL IND LTD, MUMBAI holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does SUN PHARMACEUTICAL IND LTD, MUMBAI make?
- 1 product is listed under SUN PHARMACEUTICAL IND LTD, MUMBAI in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.